With the rapid increase in the senior population, health care of older adults has become a significant task worldwide. Sarcopenia, characterized by age-related decline in the skeletal muscle mass and strength, is a newly-recognized geriatric syndrome. Due to the impact of sarcopenia on the daily lives of older people, sarcopenia may contribute to a number of adverse health outcomes, including reduced physical capability, falls, poor quality of life, disability, frailty, mortality, as well as high health care expenditures. In 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) proposed a definition for sarcopenia based on low muscle mass plus low muscle strength and/or low physical performance. Soon thereafter, the Asian Working Group for Sarcopenia (AWGS) recommended diagnostic cut-off values for sarcopenia in the Asian population. The cause of sarcopenia is considered to be multifactorial; specifically, loss of neuromuscular junctions, hormonal changes, decreased physical activity, decreased nutritional intake, and oxidative stress are all among the possible factors. Resistance exercise and nutritional supplements are generally acknowledged to be effective interventions for sarcopenia. Because sarcopenia strongly impacts millions of older adults and causes numerous health problems, it is crucial for health professionals to identify the population at high risk for sarcopenia and institute early intervention to prevent or postpone the onset of sarcopenia and further adverse health outcomes.